Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular diseasePaola Dongiovanni, Luca Valenti, Tiziana Montalcini et al.|Hepatology|2014Cited by 529
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationHarry L.A. Janssen, Jordan J. Feld, Harald Hofer et al.|Journal of Hepatology|2016Cited by 273
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsGiuseppe Cabibbo, Calogero Cammà, Ciro Celsa et al.|Journal of Hepatology|2019Cited by 205
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver DiseaseStefania Grimaudo, Salvatore Petta, Rosaria Maria Pipitone et al.|Clinical Gastroenterology and Hepatology|2019Cited by 152
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLDGrazia Pennisi, Salvatore Petta, Marco Enea et al.|Clinical Gastroenterology and Hepatology|2022Cited by 83